Accessibility links

Partner

Latest news and views from Paul Gershlick

RSS

Jaguar not stopped from terminating distribution agreement without cause based on alleged pre-contract meeting discussions – Ghanem Al-Thani Holdings v Jaguar, High Court

24 April 2012 | Paul Gershlick

Jaguar appointed Ghanem as its sole distributor in Qatar. Jaguar terminated the agreement without cause on 12 months’ notice, as it was entitled to do under the agreement. Ghanem argued that it had been...

Tags on this discussion:

3D printer development may lead to make-your-own medicines

19 April 2012 | Paul Gershlick

Glasgow University is pioneering the use of technology in which 3D printers are used to create drugs. Ultimately, they expect the technology to be used in customised drugs. The researchers said they are...

Tags on this discussion:

OECD applauds UK for improvement in bribery laws, but says more must be done on enforcement against foreign corruption

19 April 2012 | Paul Gershlick

The Organisation for Economic Co-operation and Development has praised the UK for having much improved anti-bribery and corruption laws following the high-profile introduction of the Bribery Act 2010....

Tags on this discussion:

European Commission investigates whether Motorola refused to license essential patents on fair terms and abused dominant position

16 April 2012 | Paul Gershlick

The European Commission has opened up an investigation as to whether Motorola has abused its dominant position by allegedly refusing to fairly license its patents which were essential to other players...

Tags on this discussion:

£180m fund for SMEs in life sciences industry launched

16 April 2012 | Paul Gershlick

The £180m fund for small and medium sized enterprises in the life sciences industry is being made available from 30 April, the Government has announced. Under the Biomedical Catalyst, the Medical Research...

Tags on this discussion:

Evidence of patent cliff underway with 2011 fall in NHS drug spend

5 April 2012 | Paul Gershlick

The first evidence has been emerging of the effects of the patent cliff, with NHS spending on pharmaceuticals falling from £8.83bn in 2010 to £8.81bn in 2011, according to figures from the NHS Information...

Tags on this discussion:

Most GPs think Government reforms will not improve healthcare

5 April 2012 | Paul Gershlick

55% of GPs think that the Government’s plans for commissioning of healthcare budgets to take place on a local level will not improve healthcare. Just 12% thought patients would see a noticeable improvement...

Tags on this discussion:

All Party Parliamentary Pharmacy Group hears conflicting points of view in enquiry over pharma supply chain shortage

5 April 2012 | Paul Gershlick

The All Party Parliamentary Pharmacy Group has heard conflicting evidence over the supply chain shortage that is afflicting the UK pharma industry.  On the one hand, the Association for British Pharmaceutical...

Tags on this discussion:

Information Commissioner’s Office gives guidance on efforts required to comply with data subject access requests

5 April 2012 | Paul Gershlick

The Information Commissioner’s Office – the UK’s data protection regulator - has provided guidance on complying with data subject access requests. These are requests by individuals to see the data...

Tags on this discussion:

OFT calls for investigation into private healthcare market

5 April 2012 | Paul Gershlick

The Office of Fair Trading has asked the Competition Commission to investigate the UK's £5.5bn private healthcare market. The OFT is particularly concerned that there is a lack of information about pricing...

Tags on this discussion:

Page 3 of 26812345102030...Last »